(Q35353352)

English

Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

urinary tract infection

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Wolfson JS

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Hooper DC

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 October 1989

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1655-1661

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

[Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Review of the bioavailability and pharmacokinetics of oral norfloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Comparative studies of fluoroquinolones in the treatment of urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin: a new targeted fluoroquinolone antimicrobial agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ofloxacin compared with ciprofloxacin in the treatment of complicated lower urinary tract infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

The new quinolones and their combinations with other agents for therapy of severe infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Urinary tract infections: from pathogenesis to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

12 July 2018

Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid: A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

26 September 2018

Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

26 September 2018

Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172733

26 September 2018

Ciprofloxacin and co-trimoxazole in urinary tract infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with ofloxacin in urinary tract infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of the quinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ofloxacin in the treatment of urinary tract infection in renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fleroxacin in the treatment of uncomplicated acute cystitis in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoroquinolone antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of norfloxacin in chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Centrifugation of 50 ml of peritoneal fluid is sufficient for microbiological examination in continuous ambulatory peritoneal dialysis (CAPD) patients with peritonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2686545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.33.10.1655

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35353352&oldid=1976388464"